Publicaties
2023
Wetenschappelijke publicaties
Hunt, N. B., Pajouheshnia, R., Salih, A., van Doorn, S., Souverein, P. C., Bazelier, M. T., Klungel, O. H., & Gardarsdottir, H. (2023). Prescribing of low-dose rivaroxaban in patients with atherosclerotic cardiovascular disease in the United Kingdom and the Netherlands. British Journal of Clinical Pharmacology, 89(7), 2263-2271. https://doi.org/10.1111/bcp.15708
2022
Wetenschappelijke publicaties
Leung, M. W., Bazelier, M. T., Souverein, P. C., Uitdehaag, B. M., Klungel, O. H., Leufkens, H. G., & Pajouheshnia, R. (2022). Mapping the risk of infections in patients with multiple sclerosis: A multi-database study in the United Kingdom Clinical Practice Research Datalink GOLD and Aurum. Multiple sclerosis (Houndmills, Basingstoke, England), 28(11), 1808-1818. https://doi.org/10.1177/13524585221094218
Minjon, L., van den Ban, E., Bazelier, M. T., Lalmohamed, A., Egberts, T. C. G., & Heerdink, E. R. (2022). Monitoring of Adverse Drug Reaction-Related Parameters in Children, Youth, and Young Adults Prescribed Antipsychotic Drugs by General Practitioners. Journal of Child and Adolescent Psychopharmacology, 32(1), 36-44. https://doi.org/10.1089/cap.2021.0026
2021
Wetenschappelijke publicaties
Hunt, N. B., Gardarsdottir, H., Bazelier, M. T., Klungel, O. H., & Pajouheshnia, R. (2021). A Systematic Review of How Missing Data are Handled and Reported in Multi-Database Pharmacoepidemiologic studies. Pharmacoepidemiology and Drug Safety, 30(7), 819-826. https://doi.org/10.1002/pds.5245
2020
Wetenschappelijke publicaties
Ilomäki, J., Bell, J. S., Chan, A. Y. L., Tolppanen, A. M., Luo, H., Wei, L., Lai, E. C. C., Shin, J. Y., De Paoli, G., Pajouheshnia, R., Ho, F. K., Reynolds, L., Lau, K. K., Crystal, S., Lau, W. C. Y., Man, K. K. C., Brauer, R., Chan, E. W., Shen, C. Y., ... Wong, I. C. K. (2020). Application of Healthcare ‘Big Data’ in CNS Drug Research: The Example of the Neurological and mental health Global Epidemiology Network (NeuroGEN). CNS Drugs, 34(9), 897-913. https://doi.org/10.1007/s40263-020-00742-4
2018
Wetenschappelijke publicaties
Bronsveld, H. K., De Bruin, M. L., Wesseling, J., Sanders, J., Hofland, I., Jensen, V. F., Bazelier, M. T., ter Braak, B., de Boer, A., Vestergaard, P., & Schmidt, M. K. (2018). The association of diabetes mellitus and insulin treatment with expression of insulin-related proteins in breast tumors. BMC Cancer, 18(1), [224]. https://doi.org/10.1186/s12885-018-4072-8
2017
Wetenschappelijke publicaties
Bazelier, M., Ekstrom, N., Karlstad, O., Vestergaard, P., Haukka, J., de Vries, F., Furu, K., Andersen, M., & De Bruin, M. (2017). Understanding the Treatment Choice Between Insulin Glargine, Detemir and Human Insulin: Characteristics of Patients with Type 2 Diabetes Starting Insulin in Five European Countries. Pharmacoepidemiology and Drug Safety, 26, 124-124.
But, A., De Bruin, M. L., Bazelier, M. T., Hjellvik, V., Andersen, M., Auvinen, A., Starup-Linde, J., Schmidt, M. K., Furu, K., de Vries, F., Karlstad, Ø., Ekström, N., & Haukka, J. (2017). Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study. Diabetologia, 60(9), 1691-1703. https://doi.org/10.1007/s00125-017-4312-5
2016
Wetenschappelijke publicaties
de Vries, F., Klop, C., Bazelier, M., Bijlsma, H., Leutkens, H., & Welsing, P. (2016). INCREMENTAL PREDICTIVE VALUE OF EXTENDING FRAX PREDICTORS WITH GLUCOCORTICOID DOSE AND PSYCHOTROPIC DRUGS FORTHE 10-YEAR RISK OF HIP FRACTURE. Osteoporosis International.
de Vries, F., Klop, C., Bazelier, M., Bijlsma, H., Leufkens, H., & Welsing, P. (2016). INCREMENTAL PREDICTIVE VALUE OF EXTENDING FRAX PREDICTORS WITH GLUCOCORTICOID DOSE AND PSYCHOTROPIC DRUGS FOR THE 10-YEAR RISK OF HIP FRACTURE. Osteoporosis International, 27, 630-630.
But, A., De Bruin, M. L., Bazelier, M. T., Hjellvik, V., Andersen, M., Auvinen, A., Starup-Linde, J., Schmidt, M. K., Furu, K., de Vries, F., Karlstad, O., Ekstrom, N., & Haukka, J. (2016). Cancer Risk Among Insulin Users: Comparing Analogues with Human Insulin in the CARING Five-Country Study. Pharmacoepidemiology and Drug Safety, 25, 547-547. https://researchportal.helsinki.fi/en/publications/cancer-risk-among-insulin-users-comparing-analogues-with-human-in-2
N., E., M.T., B., V., H., F., D. V., J., H., P., V., M.L., D. B., & M., A. (2016). Combining observational data from multiple databases: Comparison of individual patient data and aggregate data meta-analysis in the CARING study. 129-130. Abstract from 32nd International conference on Pharmacoepidemiology & Therapeutic Risk Management, Dublin, Ireland. https://doi.org/10.1002/pds.4070
L.M., K., J., V. D., Y.C., K., N.P., V. E., M.T., B., M.L., D. B., H.G.M., L., S., C., C., N., & F., D. V. (2016). Use of incretin agents and risk of pancreatic cancer: A population-based cohort study. Diabetes, Obesity and Metabolism, 18(3), 258-265. https://doi.org/10.1111/dom.12605
But, A., De Bruin, M. L., Bazelier, M. T., Hjellvik, V., Andersen, M., Auvinen, A., Starup-Linde, J., Schmidt, M. K., Furu, K., De Vries, F., Karlstad, Ø., Ekström, N., & Haukka, J. (2016). Cancer risk among insulin users: Comparing analogues with human insulin in the CARING five-country study. Pharmacoepidemiology and Drug Safety, 25, 545-546. https://doi.org/10.1002/pds.4070
Peeters, P. J. H. L., Bazelier, M. T., Leufkens, H. G. M., Auvinen, A., van Staa, T. P., de Vries, F., & De Bruin, M. L. (2016). Insulin glargine use and breast cancer risk: Associations with cumulative exposure. Acta Oncologica, 55(7), 851-858. https://doi.org/10.3109/0284186X.2016.1155736
Knapen, L. M., van Dalem, J., Keulemans, Y. C., van Erp, N. P., Bazelier, M. T., De Bruin, M. L., Leufkens, H. G. M., Croes, S., Neef, C., de Vries, F., & Driessen, J. H. M. (2016). Use of Incretin Agents and Risk of Pancreatic Cancer: A Population-Based Cohort Study. Diabetes, Obesity & Metabolism, 18(3), 258–265. https://doi.org/10.1111/dom.12605
Essers, I., Stolwijk, C., Boonen, A., De Bruin, M. L., Bazelier, M. T., de Vries, F., & van Tubergen, A. (2016). Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study. Annals of the Rheumatic Diseases, 75(1), 203-209. https://doi.org/10.1136/annrheumdis-2014-206147
2015
Wetenschappelijke publicaties
Peeters, P. J. H. L., Bazelier, M. T., Van Staa, T. P., Auvinen, A., Leufkens, H. G. M., de Vries, F., & De Bruin, M. L. (2015). Insulin Glargine and Breast Cancer Risk: Comparison of Different Exposure Definitions. Pharmacoepidemiology and Drug Safety, 24, 430-431.
SpringerLink (Online service) (2015). Risk of bladder cancer in patients with diabetes: a retrospective cohort study. Archives of Public Health. https://doi.org/10.1186/2049-3258-73-S1-P4
Bronsveld, H. K., Ter Braak, B., Karlstad, Ø., Vestergaard, P., Starup-Linde, J., Bazelier, M. T., de Bruin, M., De Boer, A., Siezen, C. L. E., Van De Water, B., Van Der Laan, J. W., & Schmidt, M. K. (2015). Insulin treatment and breast cancer risk; A systematic review of in vitro, animal and epidemiological evidence. Pharmacoepidemiology and Drug Safety, 24, 51-52. https://doi.org/10.1002/pds.3838
Bronsveld, H. K., ter Braak, B., Karlstad, Ø., Vestergaard, P., Starup-Linde, J., Bazelier, M. T., De Bruin, M. L., de Boer, A., Siezen, C. L. E., van de Water, B., van der Laan, J. W., & Schmidt, M. K. (2015). Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence. Breast Cancer Research, 17(1), [100]. https://doi.org/10.1186/s13058-015-0611-2
Bazelier, M. T., Eriksson, I., de Vries, F., Schmidt, M. K., Raitanen, J., Haukka, J., Starup-Linde, J., De Bruin, M. L., & Andersen, M. (2015). Data management and data analysis techniques in pharmacoepidemiological studies using a pre-planned multi-database approach: a systematic literature review. Pharmacoepidemiology and Drug Safety, 24(9), 897-905. https://doi.org/10.1002/pds.3828
Goossens, M. E., Zeegers, M. P., Bazelier, M. T., De Bruin, M. L., Buntinx, F., & de Vries, F. (2015). Risk of bladder cancer in patients with diabetes: a retrospective cohort study. BMJ Open, 5(6), e007470. https://doi.org/10.1136/bmjopen-2014-007470
Stolwijk, C., Essers, I., van Tubergen, A., Boonen, A., Bazelier, M. T., De Bruin, M. L., & de Vries, F. (2015). The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study. Annals of the Rheumatic Diseases, 74(7), 1-6. https://doi.org/10.1136/annrheumdis-2014-205253
Overige resultaten
Bazelier, M. T., Eriksson, I., De Vries, F., Schmidt, M. K., Raitanen, J., Haukka, J., Starup-Linde, J., De Bruin, M. L., & Andersen, M. (2015). Data management and data analysis techniques used in pharmacoepidemiological multi-database studies: A systematic literature review. 732. Abstract from European congress of Epidemiology 2015, Maastricht, Netherlands. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L72274361
2014
Wetenschappelijke publicaties
Essers, I., Stolwijk, C., Boonen, A., De, B. ML., Bazelier, MT., de, V. F., & van, T. A. (2014). Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study. Annals of the Rheumatic Diseases.
Essers, I., Stolwijk, C., Boonen, A., De Bruin, M. L., Bazelier, M., de Vries, F., & Van Tubergen, A. (2014). Female Patients but Not Male Patients with Ankylosing Spondylitis Are at Increased Risk of Developing Ischemic Heart Disease: A Population-Based Cohort Study. Arthritis & Rheumatology, 66, S254-S254.
MT, B., F, D. V., Vestergaard, P., RM, H., AM, G., HG, L., & TP, V. S. (2014). - Risk of fracture with thiazolidinediones: an individual patient data. Frontiers in Endocrinology, 25(8), 946-956. https://doi.org/10.3389/fendo.2013.00011
Essers, I., Stolwijk, C., Boonen, A., De Bruin, M. L., Bazelier, M. T., De Vries, F., & van Tubergen, A. (2014). Ankylosing spondylitis and risk of ischemic heart disease: A population-based cohort study. Clinical and Experimental Rheumatology, 32(5), 797.
Prieto-Alhambra, D., Güerri-Fernández, R., De Vries, F., Lalmohamed, A., Bazelier, M., Starup-Linde, J., Diez-Perez, A., Cooper, C., & Vestergaard, P. (2014). HIV infection and its association with an excess risk of clinical fractures: A nationwide case-control study. Journal of Acquired Immune Deficiency Syndromes, 66(1), 90-95. https://doi.org/10.1097/QAI.0000000000000112
Stolwijk, C., Essers, I., Van Tubergen, A., Boonen, A., Bazelier, M., De Bruin, M., & De Vries, F. (2014). The epidemiology of extra-articular manifestations in ankylosing spondylitis: A population-based matched cohort study. Annals of the Rheumatic Diseases, 73. https://doi.org/10.1136/annrheumdis-2014-eular.2833
Essers, I., Stolwijk, C., Van Tubergen, A., Boonen, A., De Bruin, M. L., Bazelier, M., & De Vries, F. (2014). Cardiovascular morbidity in patients with ankylosing spondylitis: A population-based cohort study. Annals of the Rheumatic Diseases, 73. https://doi.org/10.1136/annrheumdis-2014-eular.1853
Prieto-Alhambra, D., Güerri-Fernández, R., De Vries, F., Lalmohamed, A., Bazelier, M., Starup-Linde, J., Diez-Perez, A., Cooper, C., & Vestergaard, P. (2014). HIV infection and its association with an excess risk of clinical fractures: a nationwide case-control study. Journal of Acquired Immune Deficiency Syndromes, 66(1), 90-95. https://doi.org/10.1097/QAI.0000000000000112
Peeters, P. J. H. L., Bazelier, M. T., Uitdehaag, B. M. J., Leufkens, H. G. M., De Bruin, M. L., & de Vries, F. (2014). The risk of venous thromboembolism in patients with multiple sclerosis: the Clinical Practice Research Datalink. Journal of Thrombosis and Haemostasis, 12(4), 444-51. https://doi.org/10.1111/jth.12523
Peeters, P. J. H. L., Bazelier, M. T., Leufkens, H. G. M., de Vries, F., & De Bruin, M. L. (2014). The Risk of Colorectal Cancer in Patients With Type 2 Diabetes: Associations With Treatment Stage and Obesity. Diabetes Care. https://doi.org/10.2337/dc14-1175
Overige resultaten
Peeters, P. J. H. L., Bazelier, M. T., Leufkens, H. G. M., de Vries, F., & De Bruin, M. L. (2014). The Risk of Colorectal Cancer in Patients with Type 2 Diabetes: Associations with Treatment Stage and Obesity. 169-169. https://doi.org/10.1002/pds.3701
2013
Wetenschappelijke publicaties
Dittrich, S., Bazelier, M. T., Vestergaard, P., Henry, R., Stolk, L., Neef, K., & de Vries, F. (2013). Use of Biguanides and the Risk of Colorectal Cancer. Pharmacoepidemiology and Drug Safety.
Pouwels, S., Bazelier, M. T., de Boer, A., Weber, W. E., Neef, C., Cooper, C., & de Vries, F. (2013). Risk of fracture in patients with Parkinson's disease. Osteoporosis International. https://doi.org/10.1007/s00198-013-2300-2
Bazelier, M. T., de Vries, F., Vestergaard, P., Herings, R. M. C., Gallagher, A. M., Leufkens, H. G. M., & van Staa, T-P. (2013). Risk of Fracture with Thiazolidinediones: An Individual Patient Data Meta-Analysis. Pharmacoepidemiology and Drug Safety, 22, 286-287.
Pouwels, S., Bazelier, M. T., de Boer, A., Weber, W. E. J., Neef, C., Cooper, C., & de Vries, F. (2013). Five-year fracture risk estimation in patients with Parkinson's disease. Bone, 56(2), 266-270. https://doi.org/10.1016/j.bone.2013.06.018
Peeters, P. J. H. L., Bazelier, M. T., Vestergaard, P., Leufkens, H. G. M., Schmidt, M. K., de Vries, F., & de Bruin, M. L. (2013). Use of metformin and survival of diabetic women with breast cancer. Current Drug Safety, 8(5), 357-363.
Driessen, J., van Onzenoort, H. A., Lalmohamed, A., Klop, C., Bazelier, M., Neef, K., & de Vries, F. (2013). Use of Glucagon-Like Peptide 1 Analogues and the Risk of Fracture in Type 2 Diabetes Patients. Pharmacoepidemiology and Drug Safety, 22, 513-513.
Bazelier, M. T., de Vries, F., Vestergaard, P., Leufkens, H. G. M., & De Bruin, M. L. (2013). Use of thiazolidinediones and risk of bladder cancer: disease or drugs? Current Drug Safety, 8(5), 364-70.
Karlstad, Ø., Starup-Linde, J., Vestergaard, P., Hjellvik, V., Bazelier, M. T., Schmidt, M. K., Andersen, M., Auvinen, A., Haukka, J., Furu, K., de Vries, F., & de Bruin, M. L. (2013). Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies. Current Drug Safety, 8(5), 333-348. https://doi.org/10.2174/15680266113136660067
Knapen, L. M., Dittrich, S. T. A. M., de Vries, F., Starup-Linde, J., Vestergaard, P., Henry, R. M. A., Stolk, L. M. L., Neef, C., & Bazelier, M. T. (2013). Use of biguanides and the risk of colorectal cancer: a register-based cohort study. Current Drug Safety, 8(5), 349-356. https://doi.org/10.2174/15680266113136660068
Starup-Linde, J., Karlstad, O., Eriksen, S. A., Vestergaard, P., Bronsveld, H. K., de Vries, F., Andersen, M., Auvinen, A., Haukka, J., Hjellvik, V., Bazelier, M. T., Boer, A. D., Furu, K., & De Bruin, M. L. (2013). CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis. Current Drug Safety, 8(5), 296-332.
Bazelier, M. T., de Vries, F., Vestergaard, P., Herings, R. M. C., Gallagher, A. M., Leufkens, H. G. M., & van Staa, T-P. (2013). Risk of fracture with thiazolidinediones: an individual patient data meta-analysis. Frontiers in Endocrinology, 4, 11. https://doi.org/10.3389/fendo.2013.00011
Pouwels, S., Bazelier, M. T., de Boer, A., Weber, W. E. J., Neef, C., Cooper, C., & de Vries, F. (2013). Risk of fracture in patients with Parkinson's disease. Osteoporosis International, 24(8), 2283-90. https://doi.org/10.1007/s00198-013-2300-2
Bazelier, M. T., van Staa, T. P., Bentzen, J., Vestergaard, P., Uitdehaag, B. M. J., Leufkens, H. G. M., Stenager, E., & de Vries, F. (2013). Multiple sclerosis and fracture risk: traditional meta-analysis versus mega-analysis of individual patient data. OA Epidemiology, 1(1), 1-9. [9]. https://doi.org/10.13172/2053-079X-1-1-692
2012
Wetenschappelijke publicaties
Bazelier, M. T., Van Staa, T-P., Uitdehaag, B. M. J., Cooper, C., Leufkens, H. G. M., Vestergaard, P., Herings, R. M. C., & De Vries, F. (2012). Risk of fractures in patients with multiple sclerosis: A population-based cohort study. Neurology. https://doi.org/10.1212/WNL.0b013e318259e0ff
Bazelier, M. T., Vestergaard, P., Gallagher, A. M., van Staa, T. P., Cooper, C., Leufkens, H. G., & de Vries, F. (2012). Risk of Fracture with Thiazolidinediones: Disease or Drugs? Calcif Tissue Int. https://doi.org/10.1007/s00223-012-9591-8
Bazelier, M. T., De Vries, F., Bentzen, J., Vestergaard, P., Leufkens, H. G. M., Van Staa, T-P., & Koch-Henriksen, N. (2012). Incidence of fractures in patients with multiple sclerosis: The Danish National Health Registers. Multiple Sclerosis Journal. https://doi.org/10.1177/1352458511426739
Lalmohamed, A., Bazelier, M. T., Van Staa, T. P., Uitdehaag, B. M., Leufkens, H. G., De Boer, A., & De Vries, F. (2012). Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study. European Journal of Neurology. https://doi.org/10.1111/j.1468-1331.2012.03668.x
Bazelier, M. T., Bentzen, J., Vestergaard, P., Stenager, E., Leufkens, H. G., van Staa, T. P., & de Vries, F. (2012). The risk of fracture in incident multiple sclerosis patients: The Danish National Health Registers. Mult Scler. https://doi.org/1352458512442755 [pii]
10.1177/1352458512442755
Lalmohamed, A., Vestergaard, P., Klop, C., Bazelier, M., de Boer, A., & de Vries, F. (2012). RISK OF GASTROINTESTINAL BLEEDINGS IN PATIENTS WITH TOTAL HIP/KNEE REPLACEMENTS AND MATCHED CONTROLS: A POPULATION-BASED COHORT STUDY IN DENMARK. Osteoporosis International, 23, S563-S564.
Bazelier, M. T., Bentzen, J., Vestergaard, P., Leufkens, H. G. M., & de Vries, F. (2012). Combining Data in Multi-Country Studies: Mega-Analysis vs. Meta-Analysis. Pharmacoepidemiology and Drug Safety, 21, 11-11.
De Vries, F., Bazelier, M., Stenager, E., Vestergaard, P., & Bentzen, J. (2012). The risk of fracture in patients with incident multiple sclerosis patients in Denmark. Bone, 50, 155-156. https://doi.org/10.1016/j.bone.2012.02.486
Lalmohamed, A., Vestergaard, P., Klop, C., Bazelier, M., De Boer, A., & De Vries, F. (2012). Risk of gastrointestinal bleedings in patients with total hip/knee replacements and matched controls: A population-based cohort study in Denmark. Osteoporosis International, 23, 563-564. https://doi.org/10.1007/s00198-012-2005-y
Lalmohamed, A., Cooper, C., Bazelier, M., Cooper, A., Klop, C., de Vries, F., & Harvey, N. (2012). RISK OF FRACTURE IN PATIENTS WITH BARIATRIC SURGERY AND MATCHED CONTROLS: A POPULATION-BASED COHORT STUDY IN THE UNITED KINGDOM. Osteoporosis International, 23, 57–84. https://doi.org/10.1007/s00198-012-1923-z
Bazelier, M. T., de Vries, F., Bentzen, J., Vestergaard, P., Leufkens, H. G. M., van Staa, T-P., & Koch-Henriksen, N. (2012). Incidence of fractures in patients with multiple sclerosis: the Danish National Health Registers. Multiple sclerosis (Houndmills, Basingstoke, England), 18(5), 622-7. https://doi.org/10.1177/1352458511426739
Bazelier, M. T., Gallagher, A. M., van Staa, T-P., Cooper, C., Leufkens, H. G. M., Vestergaard, P., & de Vries, F. (2012). Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs? Pharmacoepidemiology and Drug Safety, 21(5), 507-514. https://doi.org/10.1002/pds.3234
Bazelier, M. T., Bentzen, J., Vestergaard, P., Stenager, E., Leufkens, H. G. M., van Staa, T-P., & de Vries, F. (2012). The risk of fracture in incident multiple sclerosis patients: the Danish National Health Registers. Multiple sclerosis (Houndmills, Basingstoke, England), 18(11), 1609-16. https://doi.org/10.1177/1352458512442755
Bazelier, M. T., Vestergaard, P., Gallagher, A. M., van Staa, T-P., Cooper, C., Leufkens, H. G. M., & de Vries, F. (2012). Risk of fracture with thiazolidinediones: disease or drugs? Calcified Tissue International, 90(6), 450-7. https://doi.org/10.1007/s00223-012-9591-8
Bazelier, M. T., van Staa, T-P., Uitdehaag, B. M. J., Cooper, C., Leufkens, H. G. M., Vestergaard, P., Herings, R. M. C., & de Vries, F. (2012). Risk of fractures in patients with multiple sclerosis: a population-based cohort study. Neurology, 78(24), 1967-73. https://doi.org/10.1212/WNL.0b013e318259e0ff
Lalmohamed, A., de Vries, F., Bazelier, M. T., Cooper, A., van Staa, T-P., Cooper, C., & Harvey, N. C. (2012). Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study. BMJ - Clinical research, 345, e5085.
Dobson, R., Ramagopalan, S., Giovannoni, G., Bazelier, M. T., & de Vries, F. (2012). Risk of fractures in patients with multiple sclerosis: a population-based cohort study. Neurology, 79(18), 1934-5. https://doi.org/10.1212/01.wnl.0000422676.74031.07
Lalmohamed, A., Bazelier, M. T., Van Staa, T. P., Uitdehaag, B. M. J., Leufkens, H. G. M., De Boer, A., & De Vries, F. (2012). Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study. European Journal of Neurology, 19(7), 1007-1014. https://doi.org/10.1111/j.1468-1331.2012.03668.x
Bazelier, M. T. (2012). A combinatorial approach to electronic healthcare records in pharmacoepidemiology. [Doctoral thesis 1 (Research UU / Graduation UU), Utrecht University].
https://dspace.library.uu.nl/bitstream/handle/1874/258159/bazelier.pdf?sequence=1
https://dspace.library.uu.nl/bitstream/handle/1874/258159/bazelier.pdf?sequence=1
Bazelier, M. T., Mueller-Schotte, S., Leufkens, H. G. M., Uitdehaag, B. M. J., van Staa, T., & de Vries, F. (2012). Risk of cataract and glaucoma in patients with multiple sclerosis. Multiple Sclerosis Journal, 18(5), 628-638. https://doi.org/10.1177/1352458511426737
Bazelier, M. T., van Staa, T-P., Uitdehaag, B. M. J., Cooper, C., Leufkens, H. G. M., Vestergaard, P., Bentzen, J., & de Vries, F. (2012). A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis. Neurology, 79(9), 922-928. https://doi.org/10.1212/WNL.0b013e318266faae
Overige resultaten
Bazelier, M., Bentzen, J., Vestergaard, P., Stenager, E., & de Vries, F. (2012). THE RISK OF FRACTURE IN INCIDENT MULTIPLE SCLEROSIS PATIENTS: THE DANISH NATIONAL HEALTH REGISTERS. Osteoporosis International, 23, S524-S524.
2011
Wetenschappelijke publicaties
Bazelier, M. T., Mueller-Schotte, S., van Staa, T., Uitdehaag, B., Leufkens, H., & de Vries, F. (2011). Risk of cataract in patients with multiple sclerosis: a population-based cohort study. Multiple Sclerosis Journal, 17, S306-S306.
Bazelier, M., Gallagher, A., van Staa, T., Cooper, C., Leufkens, H., Vestergaard, P., & De Vries, F. (2011). Use of Thiazolidinediones and Risk of Osteoporotic Fracture: The Danish National Databases. Pharmacoepidemiology and Drug Safety, 20, S119-S120.
Maruti, S. S., Dawn Flick, E., Bazelier, M., De Vries, F., Huybrechts, K. F., Levy, D., Roddam, A., & Dong, W. (2011). Assessing treatment patterns: Novel methods and applications. Pharmacoepidemiology and Drug Safety, 20, 267-268. https://doi.org/10.1002/pds.2206
Bazelier, M. T., Bentzen, J., Vestergaard, P., Leufkens, H., Van Staa, T., & De Vries, F. (2011). Risk of osteoporotic fracture in patients with multiple sclerosis: The Danish National Health Registers. Multiple Sclerosis, 17(10), 306. https://doi.org/10.1177/1352458511422301
Bazelier, M., Pouwels, S., Javaid, K., Cooper, C., Hilton-Jones, D., Verschuuren, J., van Staa, T., & De Vries, F. (2011). Risk of Fracture in Patients with Myasthenia Gravis. Pharmacoepidemiology and Drug Safety, 20, S119-S119.
Bazelier, M. T., van Staa, T., Uitdehaag, B. M. J., Cooper, C., Leufkens, H. G. M., Vestergaard, P., Bentzen, J., & de Vries, F. (2011). The risk of fracture in patients with multiple sclerosis: the UK general practice research database. Journal of Bone and Mineral Research, 26(9), 2271-2279. https://doi.org/10.1002/jbmr.418
Bazelier, M., de Boer, A., & de Vries, F. (2011). Acid suppressants and hip fracture: duplicate publication bias? Bone, 49(4), 920; author reply 921. https://doi.org/10.1016/j.bone.2011.07.025
Overige resultaten
Bazelier, M. T., De Vries, F., Bentzen, J., Vestergaard, P., Leufkens, H., Van Staa, T., & Koch-Henriksen, N. (2011). Incidence of fractures in patients with multiple sclerosis: the Danish National Health Registers. 85-86. https://doi.org/10.1177/1352458511422300
2010
Wetenschappelijke publicaties
Lalmohamed, A., Arden, N., van Staa, T., Leufkens, H., Bazelier, M., & de Vries, F. (2010). KNEE ARTHOPLASTY AND RISK OF HIP FRACTURE: A POPULATION-BASED CASE-CONTROL STUDY. Osteoporosis International.
Bazelier, M., van Staa, T., Leufkens, H., Vestergaard, P., Cooper, C., Uitdehaag, B., Lalmohamed, A., & de Vries, F. (2010). RISK OF FRACTURE IN PATIENTS WITH MULTIPLE SCLEROSIS: A POPULATION-BASED COHORT STUDY. Osteoporosis International, 21, S450-S451.
Lalmohamed, A., Bazelier, M. T., van Staa, T. P., & de Vries, F. (2010). Cause of Death in Patients with Multiple Sclerosis and Controls: The General Practice Research Database. Pharmacoepidemiology and Drug Safety, 19, S276-S276.
Bazelier, M., Van Staa, T., Leufkens, H., Vestergaard, P., Cooper, C., Uitdehaag, B., Lalmohamed, A., & De Vries, F. (2010). (Young Investigator Award) risk of fracture in patients with multiple sclerosis: A population-based cohort study. Osteoporosis International, 21, 450-451. https://doi.org/10.1007/s00198-010-1388-x
Müller-Schotte, S., Bazelier, M., Van Staa, T. P., Leufkens, H. G. M., & De Vries, F. (2010). Risk of cataract in patients with multiple sclerosis: A population-based cohort study. Pharmacoepidemiology and Drug Safety, 19(s1), 259-260. https://doi.org/10.1002/pds.2019
Arbouw, M., Lalmohamed, A., Souverein, P., Egberts, A., Bazelier, M., & De Vries, F. (2010). Use of dopaminergic drugs and risk of hip or femur fracture: A population-based case-control study. Bone, 47, 29. https://doi.org/10.1016/j.bone.2010.04.044
Overige resultaten
Bazelier, M. T., van Staa, T. P., Leufkens, H. G. M., Vestergaard, P., & de Vries, F. (2010). Risk of Fracture in Patients with Multiple Sclerosis: The General Practice Research Database. Abstract from Abstracts of the 26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 19-22 August 2010, Brighton, UK.